Journal of Current Research in Scientific Medicine

REVIEW ARTICLE
Year
: 2019  |  Volume : 5  |  Issue : 2  |  Page : 85--88

Shorter drug regimen of multidrug-resistant tuberculosis and the ambiguity in the World Health Organization recommendations


Rabbanie Tariq Wani1, Rehana Kausar2 
1 Department of Community Medicine, Government Medical College, Srinagar, Jammu and Kashmir, India
2 Directorate of Health Services, Srinagar, Jammu and Kashmir, India

Correspondence Address:
Rabbanie Tariq Wani
H# 39, Lane 3rd, Ibrahim Colony, Hyderpora, Srinagar, Jammu and Kashmir
India

Organizations all over world are trying to shift towards making healthcare intervention more acceptable to the consumers at large, but any intervention made has its costeffective and costbeneficial implications which should be taken into consideration while incorporating changes. A recent change of switching to shorter regimen for multidrugresistant tuberculosis (MDRTB) can be a landmark step in the treatment of the disease but it has its own limitations which need to be addressed.


How to cite this article:
Wani RT, Kausar R. Shorter drug regimen of multidrug-resistant tuberculosis and the ambiguity in the World Health Organization recommendations.J Curr Res Sci Med 2019;5:85-88


How to cite this URL:
Wani RT, Kausar R. Shorter drug regimen of multidrug-resistant tuberculosis and the ambiguity in the World Health Organization recommendations. J Curr Res Sci Med [serial online] 2019 [cited 2020 Apr 5 ];5:85-88
Available from: http://www.jcrsmed.org/article.asp?issn=2455-3069;year=2019;volume=5;issue=2;spage=85;epage=88;aulast=Wani;type=0